Chien-Min Lin

8PUBLICATIONS
8CO-AUTHORS
Solid tumoursMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Gene expression (incl. microarray and other genome-wide approaches)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 16, 2025
The HMGB1-RAGE Axis Drives the Proneural-to-Mesenchymal Transition and Aggressiveness in Glioblastoma.

Hao-Chien Yang, Yu-Kai Su, Vijesh Kumar Yadav

|May 13, 2023
NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation.

I-Chang Su, Yu-Kai Su, Syahru Agung Setiawan

|Jul 27, 2022
Ubiquitin-Specific Protease 6 n-Terminal-like Protein (USP6NL) and the Epidermal Growth Factor Receptor (EGFR) Signaling Axis Regulates Ubiquitin-Mediated DNA Repair and Temozolomide-Resistance in Glioblastoma.

I-Chang Su, Yu-Kai Su, Hao-Yu Chuang

|Sep 28, 2021
Combined Treatment with Acalabrutinib and Rapamycin Inhibits Glioma Stem Cells and Promotes Vascular Normalization by Downregulating BTK/mTOR/VEGF Signaling.

Yu-Kai Su, Oluwaseun Adebayo Bamodu, I-Chang Su

|Oct 06, 2020
Correction: Liu, H.W.; et al. Enhanced Hsa-miR-181d/p-STAT3 and Hsa-miR-181d/p-STAT5A Ratios Mediate the Anticancer Effect of Garcinol in STAT3/5A-Addicted Glioblastoma. Cancers 2019, 11, 1888.

Heng-Wei Liu, Peter Mingjui Lee, Oluwaseun Adebayo Bamodu

|Aug 14, 2020
Targeting BC200/miR218-5p Signaling Axis for Overcoming Temozolomide Resistance and Suppressing Glioma Stemness.

Yu-Kai Su, Jia Wei Lin, Jing-Wen Shih

Pageof 2

Frequent Collaborators

6 joint publications

Chi-Tai Yeh

3 joint publications

Oluwaseun Adebayo Bamodu

3 joint publications

Vijesh Kumar Yadav

2 joint publications

Syahru Agung Setiawan